SIG on Biotechnology

Chair: Dr Binodh DeSilva

Vice-Chairs: Dr Michael Ward (Australia) and Dr Hanns-Christian Mahler (Switzerland)


The FIP Biotechnology SIG is comprised of members from many diverse backgrounds in industry and academia and is dedicated to the discovery, development, and manufacturing of biotechnology-related pharmaceutical products and therapies through advances in science and technology.  The Biotechnology SIG will provide a dynamic international forum for the exchange of biotechnology-related knowledge among scientists of all disciplines to enhance their contributions to global health.  The Biotechnology SIG will offer timely biotechnology-related scientific programs, ongoing education for scientists both new and tenured to the field, as well as opportunities for networking and professional development.

The successful pharmaceutical advancement of biotechnology-related drugs requires cross-functional input from many diverse fields.  The SIG will examine both pharmaceutical progress as well as development challenges related to pharmaceutical Biotechnology in areas, including (but not limited to):

  • Bioanalytical Methods (e.g., Ligand Binding Assays)
  • Biomarkers  
  • Biosimilars / Biobetters
  • Biotherapeutics ADME   
  • Cell Therapy Products
  • Nucleic Acid Based Therapeutics 
  • Protein Aggregation and Biological Consequences 
  • Protein Optimization
  • Scale-up
  • Therapeutic Protein Immunogenicity
  • Translational Medicine
  • Vaccines 

For more information on this SIG, please contact Dr DeSilva at